top of page
FDA Abbreviated Biologics Application ("aBLA") for Biosimilar Products
Abbreviated Biologics Applications for biosimilar products are governed by 42 U.S.C. § 262. Section 262(k) requires an applicant seeking...
York Faulkner
Feb 23, 20218 min read
bottom of page